Bleeding in Liver Surgery: Prevention and Treatment

Hendriks, 2005, Intraoperative blood transfusion requirement is the main determinant of early surgical re-intervention after orthotopic liver transplantation, Transpl Int, 17, 673, 10.1007/s00147-004-0793-5 Cacciarelli, 1999, Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation, Arch Surg, 134, 25, 10.1001/archsurg.134.1.25 Stainsby, 2004, 6 Years of shot reporting–its influence on UK blood safety, Transfus Apheresis Sci, 31, 123, 10.1016/j.transci.2004.07.006 de Boer, 2005, Minimizing blood loss in liver transplantation: progress through research and evolution of techniques, Dig Surg, 22, 265, 10.1159/000088056 Porte, 2004, Blood conservation in liver transplantation: the role of aprotinin, J Cardiothorac Vasc Anesth, 18, 31S, 10.1053/j.jvca.2004.05.004 Ramos, 2003, Intraoperative red blood cell transfusion in liver transplantation: influence on patient outcome, prediction of requirements, and measures to reduce them, Liver Transpl, 9, 1320, 10.1016/jlts.2003.50204 Marietta, 2006, Pathophysiology of bleeding in surgery, Transplant Proc, 38, 812, 10.1016/j.transproceed.2006.01.047 Porte, 1989, Hemostasis in liver transplantation, Gastroenterology, 97, 488, 10.1016/0016-5085(89)90090-5 Lisman, 2007, Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment, Dig Surg, 24, 250, 10.1159/000103655 Findlay, 2000, Poor prediction of blood transfusion requirements in adult liver transplantations from preoperative variables, J Clin Anesth, 12, 319, 10.1016/S0952-8180(00)00162-8 Steib, 2001, Intraoperative blood losses and transfusion requirements during adult liver transplantation remain difficult to predict, Can J Anaesth, 48, 1075, 10.1007/BF03020372 Lodge, 2005, Recombinant coagulation factor VIIa in major liver resection: a randomized, placebo-controlled, double-blind clinical trial, Anesthesiology, 102, 269, 10.1097/00000542-200502000-00006 Planinsic, 2005, Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease, Liver Transpl, 11, 895, 10.1002/lt.20458 Groenland, 2006, Antifibrinolytics in liver transplantation, Int Anesthesiol Clin, 44, 83, 10.1097/01.aia.0000210804.39545.66 Friedman, 1999, The risk of surgery in patients with liver disease, Hepatology, 29, 1617, 10.1002/hep.510290639 Suman, 2006, Assessing the risk of surgery in patients with liver disease, Cleve Clin J Med, 73, 398, 10.3949/ccjm.73.4.398 van Gulik, 2007, Vascular occlusion techniques during liver resection, Dig Surg, 24, 274, 10.1159/000103658 Smyrniotis, 2005, Vascular control during hepatectomy: review of methods and results, World J Surg, 29, 1384, 10.1007/s00268-005-0025-x Dixon, 2005, Vascular occlusion to decrease blood loss during hepatic resection, Am J Surg, 190, 75, 10.1016/j.amjsurg.2004.10.007 van der Bilt, 2007, European survey on the application of vascular clamping in liver surgery, Dig Surg, 24, 423, 10.1159/000108325 Nakajima, 2002, Control of intraoperative bleeding during liver resection: analysis of a questionnaire sent to 231 Japanese hospitals, Surg Today, 32, 48, 10.1007/s595-002-8112-0 Selzner, 2003, Protective strategies against ischemic injury of the liver, Gastroenterology, 125, 917, 10.1016/S0016-5085(03)01048-5 Takayama, 2001, Randomized comparison of ultrasonic vs clamp transection of the liver, Arch Surg, 136, 922, 10.1001/archsurg.136.8.922 Lesurtel, 2005, How should transection of the liver be performed?: a prospective randomized study in 100 consecutive patients: comparing four different transection strategies, Ann Surg, 242, 814, 10.1097/01.sla.0000189121.35617.d7 Lisman, 2006, Consequences of abnormal hemostasis tests for clinical practice, J Thromb Haemost, 4, 2062, 10.1111/j.1538-7836.2006.02077.x Massicotte, 2004, Transfusion predictors in liver transplant, Anesth Analg, 98, 1245, 10.1213/01.ANE.0000111184.21278.07 Ozier, 2003, Institutional variability in transfusion practice for liver transplantation, Anesth Analg, 97, 671, 10.1213/01.ANE.0000073354.38695.7C Kang, 2006, Coagulation and liver transplantation, Int Anesthesiol Clin, 44, 17, 10.1097/01.aia.0000210811.77663.1e Lopez-Plaza, 2007, Transfusion guidelines and liver transplantation: time for consensus, Liver Transpl, 13, 1630, 10.1002/lt.21225 Melendez, 1998, Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction, J Am Coll Surg, 187, 620, 10.1016/S1072-7515(98)00240-3 Smyrniotis, 2004, The role of central venous pressure and type of vascular control in blood loss during major liver resections, Am J Surg, 187, 398, 10.1016/j.amjsurg.2003.12.001 Jones, 1998, Central venous pressure and its effect on blood loss during liver resection, Br J Surg, 85, 1058, 10.1046/j.1365-2168.1998.00795.x Bismuth, 1989, Major hepatic resection under total vascular exclusion, Ann Surg, 210, 13, 10.1097/00000658-198907000-00002 Schroeder, 2004, Intraoperative fluid management during orthotopic liver transplantation, J Cardiothorac Vasc Anesth, 18, 438, 10.1053/j.jvca.2004.05.020 Massicotte, 2006, Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations, Liver Transpl, 12, 117, 10.1002/lt.20559 Wang, 2006, Low central venous pressure reduces blood loss in hepatectomy, World J Gastroenterol, 12, 935, 10.3748/wjg.v12.i6.935 Hashimoto, 2007, Intraoperative blood salvage during liver resection: a randomized controlled trial, Ann Surg, 245, 686, 10.1097/01.sla.0000255562.60215.3b Porte, 2002, Pharmacological strategies to decrease transfusion requirements in patients undergoing surgery, Drugs, 62, 2193, 10.2165/00003495-200262150-00003 Berrevoet, 2007, Use of topical hemostatic agents during liver resection, Dig Surg, 24, 288 Heaton, 2005, Advances and methods in liver surgery: haemostasis, Eur J Gastroenterol Hepatol, 17, S3, 10.1097/00042737-200504001-00002 Chapman, 2000, Effective control of hepatic bleeding with a novel collagen-based composite combined with autologous plasma: results of a randomized controlled trial, Arch Surg, 135, 1200, 10.1001/archsurg.135.10.1200 Schwartz, 2004, Comparison of a new fibrin sealant with standard topical hemostatic agents, Arch Surg, 139, 1148, 10.1001/archsurg.139.11.1148 Jackson, 2001, Fibrin sealants in surgical practice: an overview, Am J Surg, 182, 1S, 10.1016/S0002-9610(01)00770-X Carless, 2003, Fibrin sealant use for minimising peri-operative allogeneic blood transfusion, Cochrane Database Syst Rev, 1 Figueras, 2007, Application of fibrin glue sealant after hepatectomy does not seem justified: results of a randomized study in 300 patients, Ann Surg, 245, 536, 10.1097/01.sla.0000245846.37046.57 Xia, 2005, Antifibrinolytics in orthotopic liver transplantation: current status and controversies, Liver Transpl, 11, 10, 10.1002/lt.20275 Ozier, 2006, Pharmacological approaches to reducing blood loss and transfusions in the surgical patient, Can J Anaesth, 53, S21, 10.1007/BF03022249 Henry, 2007, Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion, Cochrane Database Syst Rev, 4, 10.1002/14651858.CD001886.pub2 Dalmau, 2000, Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation, Anesth Analg, 91, 29, 10.1213/00000539-200007000-00006 Molenaar, 2007, Efficacy and safety of antifibrinolytic drugs in liver transplantation: a systematic review and meta-analysis, Am J Transplant, 7, 185, 10.1111/j.1600-6143.2006.01591.x Warnaar, 2007, The impact of aprotinin on renal function after liver transplantation: an analysis of 1,043 patients, Am J Transplant, 7, 2378, 10.1111/j.1600-6143.2007.01939.x Lentschener, 1997, Aprotinin reduces blood loss in patients undergoing elective liver resection, Anesth Analg, 84, 875, 10.1213/00000539-199704000-00032 Wu, 2006, Perioperative parenteral tranexamic acid in liver tumor resection: a prospective randomized trial toward a “blood transfusion”-free hepatectomy, Ann Surg, 243, 173, 10.1097/01.sla.0000197561.70972.73 Pereboom, 2007, Aprotinin and nafamostat mesilate in liver surgery: effect on blood loss, Dig Surg, 24, 282, 10.1159/000103659 Lodge, 2005, Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation, Liver Transpl, 11, 973, 10.1002/lt.20470 Hendriks, 2001, Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation: a pilot study, Transplantation, 71, 402, 10.1097/00007890-200102150-00011 Meijer, 2003, Recombinant factor VIIa in orthotopic liver transplantation: influence on parameters of coagulation and fibrinolysis, Blood Coagul Fibrinolysis, 14, 169, 10.1097/00001721-200302000-00008 Vincent, 2006, Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding–a European perspective, Crit Care, 10, R120, 10.1186/cc5026 Levy, 2006, Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile, Transfusion, 46, 919, 10.1111/j.1537-2995.2006.00824.x